Group Cfo
CurrentCFO of Biovica International. Primary responsibility is to lead Finance and prepare Biovica for the commercialization of Biovica's biomarker assays.Biovica develops and commercializes blood-based biomarker assays that help oncologists monitor cancer progression. Biovica’s assay, DiviTum® TKa, measures cell proliferation by detecting the TKa biomarker in the bloodstream. The assay has demonstrated its ability to provide insight to therapy effectiveness in several clinical trials.